Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 7×
“AQ4 N undergoes an oxygen-dependent 2e- reduction to the mono-N-oxide intermediate AQM before a further oxygendependent 2e- reduction to form the toxic product AQ4 [104].”
BackgroundInfluentialNitric oxide synthases in mammals
Knowles, R. G., & Moncada, S. (1994) · Biochemical Journal · doi:10.1042/bj2980249 · Cited by 2,752
Giantonio, B. J., Catalano, P. J., Meropol, N. J., O'Dwyer, P. J., Mitchell, E. P., Alberts, S. R., Schwartz, M. A., & Benson, A. B. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6305 · Cited by 2,279 · cited 1×
“The therapeutic activity of anti-VEGF monoclonal antibody, bevacizumab, recently approved for patients with colorectal cancer is associated with inhibition of NO production [85].”
BackgroundHMGB1 and RAGE in Inflammation and Cancer
Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., & Coyle, A. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132603 · Cited by 1,436 · cited 1×
“It binds with high affinity to several receptors including the receptor for advanced glycation end products (RAGE) and toll-like receptors (TLR)-2, TLR-4, TLR-9, thereby promoting inflammation [10].”
BackgroundBlockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Nitric oxide synthase activity in human breast cancer
Thomsen, L., Miles, D., Happerfield, L., Bobrow, L., Knowles, R., & Moncada, S. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.274 · Cited by 626
Nitric Oxide Impairs Normoxic Degradation of HIF-1α by Inhibition of Prolyl Hydroxylases
Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0791 · Cited by 414
Life history of eNOS: partners and pathways
DUDZINSKI, D., & MICHEL, T. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.023 · Cited by 400
A p53 Amino-Terminal Nuclear Export Signal Inhibited by DNA Damage-Induced Phosphorylation
Zhang, Y., & Xiong, Y. (2001) · Science · doi:10.1126/science.1058637 · Cited by 378 · cited 1×
“The introduction of p53 gene into cells lacking functional p53 enhanced the synergy, which was due to the phosphorylation of p53 on serine 15 [68].”
BackgroundThomas, D. D., Espey, M. G., Ridnour, L. A., Hofseth, L. J., Mancardi, D., Harris, C. C., & Wink, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400453101 · Cited by 289
The biphasic nature of nitric oxide responses in tumor biology
Ridnour, L. A., Thomas, D. D., Donzelli, S., Espey, M. G., Roberts, D. D., Wink, D. A., & Isenberg, J. S. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1329 · Cited by 247 · cited 1×
“These discrete NO-signalling profiles suggest that NO concentration can be finely tuned to elicit different biologic responses, which has recently been extended by studies identifying an NO biphasic angiogenic response [43].”
BackgroundCooper, C. E., & Giulivi, C. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00310.2006 · Cited by 176
Abnormalities in nitric oxide and its derivatives in lung cancer
Masri, F. A., Comhair, S. A. A., Koeck, T., Xu, W., Janocha, A., Ghosh, S., Dweik, R. A., Golish, J., Kinter, M., Stuehr, D. J., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1523oc · Cited by 128 · cited 1×
“During the last two decades, iNOS has been reported to be associated with several human malignant tumours including breast [14], brain [15], lung [16], prostate [17], colorectal [18] and pancreatic carcinomas [19], Kaposi’s Fig.”
BackgroundWest, M. B., Hill, B. G., Xuan, Y.-T., Bhatnagar, A., West, M. B., Hill, B. G., Xuan, Y.-T., & Bhatnagar, A. (2006) · The FASEB Journal · doi:10.1096/fj.06-5843fje · Cited by 116 · cited 4×
“In addition, glutathione could potentially replace the NO on S-nitrosylated proteins, converting the proteins to an S-glutathiolated form via reversible disulfide bonds, and thus dynamically regulating the protein function [53].”
BackgroundInfluentialNitric oxide synthase as a marker in colorectal carcinoma
Lagares-Garcia, J. A., Moore, R. A., Collier, B., Heggere, M., Diaz, F., & Qian, F. (2001) · The American Surgeon · doi:10.1177/000313480106700726 · Cited by 62 · cited 1×
“During the last two decades, iNOS has been reported to be associated with several human malignant tumours including breast [14], brain [15], lung [16], prostate [17], colorectal [18] and pancreatic carcinomas [19], Kaposi’s Fig.”
BackgroundYakovlev, V. A., Bayden, A. S., Graves, P. R., Kellogg, G. E., & Mikkelsen, R. B. (2010) · Biochemistry · doi:10.1021/bi100564w · Cited by 56 · cited 1×
“NO induced the phosphorylation of p53 in these cells via the kinase ATR (ataxia telangiectasia and Rad3 related) and promoted p53 nuclear retention [70].”
Background
Cited by
Graves, D. B. (2012) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/45/26/263001 · Cited by 1,518
Arnold, R. S., Sun, Q., Sun, C. Q., Richards, J. C., O'Hearn, S., Osunkoya, A. O., Wallace, D. C., & Petros, J. A. (2013) · BioMed Research International · doi:10.1155/2013/239257 · Cited by 736
Nitric oxide and cancer: a review
Korde Choudhari, S., Chaudhary, M., Bagde, S., Gadbail, A. R., & Joshi, V. (2013) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-11-118 · Cited by 634
The dual role of iNOS in cancer
Vannini, F., Kashfi, K., & Nath, N. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.009 · Cited by 524
Genard, G., Lucas, S., & Michiels, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00828 · Cited by 419
Metadata
- Authors
- Singh, S., & Gupta, A. K.
- Venue
- Cancer Chemotherapy and Pharmacology
- Published
- 2011-05-05
- Volume
- 67
- Issue
- 6
- Pages
- 1211-1224
- ISSN
- 0344-5704 (ISSN-L)
- 1432-0843
- OpenAlex
- W1992179114
- Cited by
- 212
- References
- 16
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.